At a glance
ClinicalIndex Comparison Record- ✓Age 12-18 years
- ✓Presenting for well care or follow-up visits at study sites
- ✓Any level of substance use
- ✓Able to read and understand English
- ✕Will not be available for 12-month follow-up period
- ✕Medically unstable at the time of the visit
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Screening and Brief Advice to Reduce Teen Substance Use
In Brief
A clinical study evaluating cSBA - New England, USA and cSBA - Prague, CZR for Substance Related Disorders. Completed, enrolled 2,695 participants across 6 sites in 2 countries.
Detailed Summary
The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR). We hypothesize that: 1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use; 2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use; 3. Among 12-18 year old well care patients who are at risk for riding with an impaired driver or driving while impaired, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing Riding/Driving risk behavior as measured by a standardized scale.
Study Details
Timeline
Interventions
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.